Distribution of <i>SRSF2</i> mutations in MDS patients.

WBC, white blood cell count; WHO, World Health Organization; RA, refractory anemia; RARS, refractory anemia with ringed sideroblasts; RCMD, refractory cytopenia with multilineage dysplasia; RCMD-RS, refractory cytopenia with multilineage dysplasia with ringed sideroblasts; RAEB, refractory anemia with excess of blasts; del(5q), MDS with isolated del(5q); MDS-U, myelodysplastic syndrome unclassifiable; IPSS, International Prognostic Scoring System. Distribution of SRSF2 mutations in MDS patients.WBC：白细胞计数（white blood cell count）；WHO：世界卫生组织（World Health Organization）；RA：难治性贫血（refractory anemia）；RARS：环形铁粒幼红细胞性难治性贫血（refractory anemia with ringed sideroblasts）；RCMD：多系发育异常性难治性血细胞减少症（refractory cytopenia with multilineage dysplasia）；RCMD-RS：伴环形铁粒幼红细胞的多系发育异常性难治性血细胞减少症（refractory cytopenia with multilineage dysplasia with ringed sideroblasts）；RAEB：原始细胞过多性难治性贫血（refractory anemia with excess of blasts）；del(5q)：伴孤立性5号染色体长臂缺失的骨髓增生异常综合征（myelodysplastic syndrome with isolated del(5q)，缩写MDS）；MDS-U：未分类骨髓增生异常综合征（myelodysplastic syndrome unclassifiable，缩写MDS-U）；IPSS：国际预后评分系统（International Prognostic Scoring System）。 骨髓增生异常综合征（MDS）患者中SRSF2基因突变的分布情况。